Gsk (GSK) Cash & Current Investments (2009 - 2026)
Gsk (GSK) posted Cash & Current Investments of $4.7 billion for Q4 2025, down 8.37% on a QoQ basis from $5.1 billion in Q4 2024, and down 8.37% year-over-year from $5.1 billion in Q4 2024.
Gsk (GSK) has 11 years of Cash & Current Investments data on file, last reported at $4.7 billion in Q4 2025.
- In Q4 2025, Cash & Current Investments fell 8.37% year-over-year to $4.7 billion; the TTM figure through Dec 2025 stood at $4.7 billion (down 8.37% YoY), while the FY2025 annual figure was $4.7 billion, down 8.37% from the prior year.
- Cash & Current Investments fell to $4.7 billion in Q4 2025, from $5.1 billion in the prior quarter.
- Across five years, Cash & Current Investments topped out at $9.2 billion in Q4 2022 and bottomed at $4.7 billion in Q4 2025.
- A 5-year average of $6.2 billion and a median of $5.8 billion in 2021 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2021 — Cash & Current Investments sank 32.29% — and 2022, when it jumped 59.0%.
- Year by year, Cash & Current Investments stood at $5.8 billion in 2021, then jumped by 59.0% to $9.2 billion in 2022, then sank by 30.36% to $6.4 billion in 2023, then retreated by 19.95% to $5.1 billion in 2024, then dropped by 8.37% to $4.7 billion in 2025.
- The last three Cash & Current Investments figures came in at $4.7 billion (Q4 2025), $5.1 billion (Q4 2024), and $6.4 billion (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 5.28 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 22.05 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 9.39 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 5.70 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 12.04 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 7.64 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 13.08 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 10.49 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 4.68 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.38 Bn |
| Dec 31, 2025 | 4.68 Bn |
| Sep 30, 2025 | 4.30 Bn |
| Jun 30, 2025 | 5.07 Bn |
| Mar 31, 2025 | 5.74 Bn |
| Dec 31, 2024 | 5.11 Bn |
| Sep 30, 2024 | 4.15 Bn |
| Jun 30, 2024 | 3.61 Bn |
| Mar 31, 2024 | 3.45 Bn |
| Dec 31, 2023 | 6.38 Bn |
| Sep 30, 2023 | 4.21 Bn |
| Jun 30, 2023 | 4.13 Bn |
| Mar 31, 2023 | 3.66 Bn |
| Dec 31, 2022 | 9.16 Bn |
| Sep 30, 2022 | 3.87 Bn |
| Jun 30, 2022 | 8.27 Bn |
| Mar 31, 2022 | 14.69 Bn |
| Dec 31, 2021 | 5.76 Bn |
| Sep 30, 2021 | 5.03 Bn |
| Jun 30, 2021 | 5.04 Bn |
| Mar 31, 2021 | 6.88 Bn |
| Dec 31, 2020 | 8.51 Bn |
| Sep 28, 2020 | 10.34 Bn |
| Jun 30, 2020 | 10.66 Bn |
| Mar 31, 2020 | 7.71 Bn |
| Dec 31, 2019 | 6.15 Bn |
| Sep 30, 2019 | 5.95 Bn |
| Jun 30, 2019 | 4.98 Bn |
| Mar 31, 2019 | 5.06 Bn |
| Dec 31, 2018 | 5.09 Bn |
| Sep 30, 2018 | 4.86 Bn |
| Jun 30, 2018 | 5.63 Bn |
| Mar 31, 2018 | 5.78 Bn |
| Dec 31, 2017 | 5.18 Bn |
| Sep 30, 2017 | 5.93 Bn |
| Jun 30, 2017 | 4.97 Bn |
| Mar 31, 2017 | 5.38 Bn |
| Dec 31, 2016 | 6.28 Bn |
| Sep 30, 2016 | 5.80 Bn |
| Jun 30, 2016 | 5.70 Bn |
| Mar 31, 2016 | 7.19 Bn |
| Dec 31, 2015 | 8.61 Bn |
| Sep 30, 2015 | 11.15 Bn |
| Jun 30, 2015 | 11.95 Bn |
| Mar 31, 2015 | 15.43 Bn |
| Dec 31, 2014 | 6.23 Bn |
| Sep 30, 2014 | 6.45 Bn |
| Jun 30, 2014 | 5.16 Bn |
| Mar 31, 2014 | 5.66 Bn |
| Dec 31, 2013 | 9.21 Bn |
| Sep 30, 2013 | 5.28 Bn |
| Jun 30, 2013 | 4.60 Bn |
| Mar 31, 2013 | 6.14 Bn |
| Dec 31, 2012 | 6,423.38 Bn |
| Sep 30, 2012 | 5.23 Bn |
| Jun 30, 2012 | 11.81 Bn |
| Mar 31, 2012 | 8.99 Bn |
| Dec 31, 2011 | 12,572.26 Bn |
| Sep 30, 2011 | 8.43 Bn |
| Jun 30, 2011 | 9.18 Bn |
| Mar 31, 2011 | 10.13 Bn |
| Dec 31, 2010 | 9.27 Bn |
| Sep 30, 2010 | 9.30 Bn |
| Jun 30, 2010 | 9.50 Bn |
| Mar 31, 2010 | 10.67 Bn |
| Dec 31, 2009 | 10.42 Bn |
| Sep 30, 2009 | 11.08 Bn |
| Jun 30, 2009 | 7.66 Bn |
| Mar 31, 2009 | 9.31 Bn |